| The relationships between time in range, hyperglycemia metrics, and HbA1c RW Beck, RM Bergenstal, P Cheng, C Kollman, AL Carlson, ML Johnson, ... Journal of diabetes science and technology 13 (4), 614-626, 2019 | 437 | 2019 |
| Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial T Martens, RW Beck, R Bailey, KJ Ruedy, P Calhoun, AL Peters, ... Jama 325 (22), 2262-2272, 2021 | 310 | 2021 |
| A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial RM Bergenstal, R Nimri, RW Beck, A Criego, L Laffel, D Schatz, ... The Lancet 397 (10270), 208-219, 2021 | 282 | 2021 |
| Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial RE Pratley, LG Kanapka, MR Rickels, A Ahmann, G Aleppo, R Beck, ... Jama 323 (23), 2397-2406, 2020 | 230 | 2020 |
| Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, ... Diabetes Care 44 (7), 1630-1640, 2021 | 171 | 2021 |
| Clinical use of continuous glucose monitoring in adults with type 2 diabetes AL Carlson, DM Mullen, RM Bergenstal Diabetes technology & therapeutics 19 (S2), S-4-S-11, 2017 | 171 | 2017 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 168 | 2023 |
| Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes AL Carlson, JL Sherr, DI Shulman, SK Garg, R Pop-Busui, BW Bode, ... Diabetes technology & therapeutics 24 (3), 178-189, 2022 | 138 | 2022 |
| Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice ML Johnson, TW Martens, AB Criego, AL Carlson, GD Simonson, ... Diabetes technology & therapeutics 21 (S2), S2-17-S2-25, 2019 | 93 | 2019 |
| Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) Study Group. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a … RE Pratley, LG Kanapka, MR Rickels, A Ahmann, G Aleppo, R Beck, ... Jama 323 (23), 2397-2406, 2020 | 80 | 2020 |
| Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: efficacy and safety from a randomized double‐blind trial JB Buse, AL Carlson, M Komatsu, O Mosenzon, L Rose, B Liang, ... Diabetes, Obesity and Metabolism 20 (12), 2885-2893, 2018 | 67 | 2018 |
| Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes KM Miller, LG Kanapka, MR Rickels, AJ Ahmann, G Aleppo, L Ang, ... Diabetes technology & therapeutics 24 (6), 424-434, 2022 | 43 | 2022 |
| Real-world evidence supporting tandem control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations GP Forlenza, AL Carlson, RJ Galindo, DF Kruger, CJ Levy, JB McGill, ... Diabetes technology & therapeutics 24 (11), 814-823, 2022 | 30 | 2022 |
| Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM study AL Carlson, LG Kanapka, KM Miller, AJ Ahmann, NS Chaytor, S Fox, ... Journal of Diabetes Science and Technology 15 (3), 582-592, 2021 | 30 | 2021 |
| HbA1c: the glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice AL Carlson, AB Criego, TW Martens, RM Bergenstal Endocrinology and Metabolism Clinics 49 (1), 95-107, 2020 | 30 | 2020 |
| Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy D Zylla, G Gilmore, J Eklund, S Richter, A Carlson Journal of Diabetes and its Complications 33 (4), 335-339, 2019 | 29 | 2019 |
| Advanced technology in the management of diabetes: which comes first—continuous glucose monitor or insulin pump? CT Martin, AB Criego, AL Carlson, RM Bergenstal Current diabetes reports 19, 1-9, 2019 | 27 | 2019 |
| How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the … WH Polonsky, KK Hood, CJ Levy, SA MacLeish, IB Hirsch, SA Brown, ... Diabetes research and clinical practice 190, 109998, 2022 | 26 | 2022 |
| Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system B Bode, A Carlson, R Liu, T Hardy, R Bergenstal, J Boyd, S Morrett, ... Diabetes technology & therapeutics 23 (12), 828-836, 2021 | 26 | 2021 |
| Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis AL Carlson, TD Daniel, A DeSantis, S Jabbour, EK French, D Kruger, ... BMJ Open Diabetes Research and Care 10 (1), e002590, 2022 | 25 | 2022 |
